Expression of Y-box-binding protein dbpC/contrin, a potentially new cancer/testis antigen

18Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Y-box-binding proteins are members of the human cold-shock domain protein superfamily, which includes dbpA, dbpB/YB-1, and dbpC/contrin. dbpC/contrin is a germ cell-specific Y-box-binding protein and is suggested to function as a nuclear transcription factor and RNA-binding protein in the cytoplasm. Whereas ubiquitous dbpB/YB-1 expression has been well studied in various types of human carcinomas as a prognostic or predictive marker, the dbpC/contrin expression in human tumour cells has not been reported. In this report, we provide the first evidence showing that dbpC was highly expressed in human testicular seminoma and ovarian dysgerminomas, and in carcinomas in other tissues and that its expression in normal tissues is nearly restricted to germ cells and placental trophoblasts. These results indicate that dbpC/contrin would be a potentially novel cancer/testis antigen. © 2006 Cancer Research.

Cite

CITATION STYLE

APA

Kohno, Y., Matsuki, Y., Tanimoto, A., Izumi, H., Uchiumi, T., Kohno, K., … Sasaguri, Y. (2006). Expression of Y-box-binding protein dbpC/contrin, a potentially new cancer/testis antigen. British Journal of Cancer, 94(5), 710–716. https://doi.org/10.1038/sj.bjc.6602987

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free